BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/5/2026 2:51:02 AM | Browse: 3 | Download: 1
 |
Received |
|
2026-06-03 07:12 |
|
Peer-Review Started |
|
2026-06-03 07:12 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-06-17 00:53 |
|
Revised |
|
2026-06-17 08:47 |
|
Publication Fee Transferred |
|
2026-06-30 10:03 |
|
Second Decision by Editor |
|
2026-07-17 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-07-17 06:21 |
|
Articles in Press |
|
2026-07-17 06:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-10-19 00:37 |
|
Publish the Manuscript Online |
|
2026-11-05 02:51 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Nab-paclitaxel-oxaliplatin-S-1 vs FOLFOX in locally advanced gastric cancer: Efficacy and postoperative disease-free survival prediction
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bao-Yan Ji, Lu-Lu Qi, De-Yan Fan, Yun Zhang, Li He, Kuan Zhang and Zhi-Bo Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Qinghai Red Cross Hospital Institutional Self-selected Research Project |
No. YNZXKT2026023 |
|
| Corresponding Author |
Zhi-Bo Liu, Professor, Department of Oncology, Qinghai Red Cross Hospital, No. 55 South Street, Chengzhong District, Xining 810000, Qinghai Province, China. liuzhibo0965@163.com |
| Key Words |
Gastric cancer; FOLFOX; P-SOX; Disease-free survival; Nomogram |
| Core Tip |
This retrospective two-center study compared FOLFOX and P-SOX regimens in patients with locally advanced gastric cancer undergoing perioperative chemotherapy and D2 radical gastrectomy. P-SOX showed numerically higher radiological and pathological response rates than FOLFOX, but the differences were not statistically significant. Survival curves also suggested a favorable trend for P-SOX without significant disease-free survival or overall survival improvement. A least absolute shrinkage and selection operator-Cox-based nomogram incorporating clinical tumor node metastasis stage, tumor regression grade response, and pre-chemotherapy tumor diameter was developed to predict 18-month, 24-month, and 36-month disease-free survival, providing a practical tool for postoperative recurrence risk stratification. |
| Publish Date |
2026-11-05 02:51 |
| Citation |
Ji BY, Qi LL, Fan DY, Zhang Y, He L, Zhang K, Liu ZB. Nab-paclitaxel-oxaliplatin-S-1 vs FOLFOX in locally advanced gastric cancer: Efficacy and postoperative disease-free survival prediction. World J Gastrointest Oncol 2026; 18(11): 123857
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i11/123857.htm |
| DOI |
https://doi.org/10.4251/wjgo.123857 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
